Birmingham, West Midlands -- (SBWIRE) -- 10/21/2013 -- Value Penny Stocks issues special report on Immunomedics, Inc. (NASDAQ:IMMU), Amdocs Limited (NYSE:DOX), Celldex Therapeutics, Inc. (NASDAQ:CLDX), ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD).
Immunomedics, Inc. (NASDAQ:IMMU) ended its recent business day with the loss of -11.56% and closed at the price of $4.47 after opening at $5.13. The stock traded during its last trading session with the total volume of 3,120,950 shares, as compared to its average volume of 1.20 million shares. Immunomedics, Inc., a biopharmaceutical company, focuses on the development of monoclonal antibody-based products for the targeted treatment of cancer, autoimmune, and other serious diseases.
Has IMMU Found The Bottom and Ready To Move Up? Find Out Here
Amdocs Limited (NYSE:DOX) remained among the day advancers and traded with volume of 3,106,057 shares in the last session, as compared to average volume of 1.81 million shares. In comparison with 52 week range of $31.41 - $39.01, it faced lowest price of $37.00 during the last trading session whereas its day highest price was $37.41. The company’s total market capitalization is $6.02 billion, along with 160.98 million shares outstanding. Amdocs Limited, together with its subsidiaries, provides software and services for communications, media, and entertainment industry service providers worldwide.
For How Long DOX’s Gloss will Attract Investors? Find out via this report
Celldex Therapeutics, Inc. (NASDAQ:CLDX) showed 3,102,995 shares in volume during the last trading session, while the average trading volume remained 3.41 million shares. The stock kicked off its trading session at $27.38 and closed at $25.80 after declining -4.44%. Celldex Therapeutics, Inc., a biopharmaceutical company, focuses on the development, manufacture, and commercialization of novel therapeutics for human health care primarily in the United States.
Why Should Investors Buy CLDX After the Recent Fall? Just Go Here and Find Out
ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) stock traded during its last trading session with the total traded volume of 3,099,157 shares versus its average volume of 3.41 million shares. The company opened its trade at the price of $24.85 and its closing price was $23.99 after losing -2.60% for the day. ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on innovative treatments that address unmet medical needs in neurological and related central nervous system disorders.
Will ACAD Get Buyers Even After The Recent Rally? Find Out Here
About Value Penny Stocks:
Value Penny Stocks was made by Two Active traders, Steve and Wilson, whom have made a platform for traders in order to provide traders the #1 Penny Stock Newsletter which actually gives value to your money and makes your portfolio full of profits. We concentrate on small cap stocks that trade on NYSE, NASD, AMEX, OTCBB, and OTC exchanges. These are usually stocks that will trade under $5 a share and offer the utmost potential profit on your short or long term investment. We also devote ourselves to understanding the overall market situations and use this knowledge in order to gain a better perception during our stock picking decisions.
We at ValuePennyStocks.com are engaged in the business of marketing and advertising companies. All content on our website is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. Neither the information presented nor any statement or expression of opinion, or any other matter herein, directly or indirectly constitutes a solicitation of the purchase or sale of any securities.
Please Read Our Full Disclaimer at: http://www.valuepennystocks.com/disclaimer/
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)